Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

The family of Cole Schmidtknecht accuse OptumRx and Walgreens of having a part in their son’s death. As we reported last month, the 22-year-old didn’t have an asthma inhaler when he suffered a ...

The state’s insurance regulator has demanded detailed information about patients and their medications, raising privacy ...

Express Scripts, Caremark and Optum Rx are turning to an appeals court to try to reverse a legal setback in their ongoing feud with the Federal Trade Commission. The PBMs said on Friday they will ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

In the lawsuit complaint, Cole's parents, Bil and Shanon Schmidtknecht, allege both OptumRx and Walgreens were negligent and bear responsibility for their son's death. Five days before Cole's ...

Vertex Pharma (VRTX) stock slips as UnitedHealth (UNH) offers its pain drug Journavx Tier 3 coverage, setting a rivalry with ...

In September, the FTC sued Caremark, Express Scripts and Optum Rx over business practices that regulators said were artificially driving up the cost of insulin. The three PBMs, which are owned by ...

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...